Signaling by mutant K-RAS into the ERK1/2, ERK5, JNK and PI3K pathways plays key roles in the transforming, growth promoting and apoptosis-resistant phenotype of mutant K-RAS expressing tumor cells. Here, KRAS is linked to neoplasm.